GBNH
Get informed when a big investor buys or sells
+ Follow| Market cap | $5.52 Million |
|---|---|
| Enterprise Value | $40.25 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.73 |
| Beta | 1.74 |
| Outstanding Shares | 42,232,942 |
| P/E Ratio | -0.03 |
|---|---|
| PEG | -2.26 |
| Price to Sales | 0.12 |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 0.7 |
| Enterprise Value to EBIT | -1.56 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.95 |
| Debt to Equity | -0.31 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Operating through 123 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared,non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the Unite...